|
|
|
|
Direct Cost |
Indirect Cost |
|
1F99AG079802-01 |
Elucidate the adverse impact of mitochondria-induced oxidative stress in molecular and cellular determinants in the aging lung, driving susceptibility to Mycobacterium tuberculosis infection |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIA |
$37,532 |
|
$37,532 |
1P30AI168439-01 |
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$638,353 |
$561,015 |
$1,199,368 |
1R01AI157850-01A1 |
Role of cellular long non-coding RNAs in HIV replication and disease outcome |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$250,000 |
$235,200 |
$485,200 |
1R01AI170197-01 |
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$499,886 |
$489,888 |
$989,774 |
1R01AI172539-01 |
Durable HIV Vaccine Targeting Mucosal Epithelium |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$499,936 |
$489,937 |
$989,873 |
1R01MH130193-01 |
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIMH |
$599,449 |
$315,949 |
$915,398 |
1R21AI165289-01A1 |
Pigtail Macaque Model of Human-Simian Immunodeficiency Virus Infection |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$200,000 |
$178,000 |
$378,000 |
1R21AI170148-01 |
Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$211,349 |
$201,157 |
$412,506 |
1R21AI171601-01 |
Role of the microbiome of the schistosome snail host |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$125,000 |
$122,500 |
$247,500 |
1R25GM142021-01A1 |
Its Contagious! Promoting the Biomedical Workforce Pipeline through Infectious Diseases |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIGMS |
$250,000 |
$15,200 |
$265,200 |
1R61AI169026-01 |
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$458,709 |
$97,857 |
$556,566 |
1S10OD032443-01 |
Dual Beckman Coulter DxH 690T and Beckman Coulter DxH 560 AL |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$85,775 |
|
$85,775 |
3P51OD011133-24S1 |
Imaging microglial activation in aged marmosets |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$261,834 |
$158,030 |
$419,864 |
3P51OD011133-24S2 |
The Southwest National Primate Research Center: Rhesus Macaque Expansion |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$1,315,102 |
$941,586 |
$2,256,688 |
3P51OD011133-24S3 |
Diversity Supplement - Ruby Escobedo |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$37,000 |
$36,260 |
$73,260 |
3P51OD011133-24S4 |
Optimization of Marmoset Sperm Cryopreservation |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$374,274 |
$125,670 |
$499,944 |
3P51OD011133-24S5 |
Mechanistic interrogation of the role of Type I IFN pathway in protection from SARS-CoV-2 infection in nonhuman primates |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$264,550 |
$235,449 |
$499,999 |
3R01DA052845-03S1 |
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection-supplement |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIDA |
$249,999 |
$222,499 |
$472,498 |
5F32AI152348-03 |
Linking Receptor-Mediated Phagocytosis and cAMP Pathways in Macrophage Responses to Tuberculosis |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
NIAID |
$79,153 |
|
$79,153 |
5K01OD031898-02 |
Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic |
TEXAS BIOMEDICAL RESEARCH INSTITUTE |
OD |
$174,999 |
$13,957 |
$188,956 |